Relevance. Retinopathy of prematurity (ROP) is among the primary causes of childhood blindness, particularly in countries with well-developed neonatal care systems. Emerging evidence points to the importance of hormonal regulators in angiogenesis, including fibroblast growth factor 23 (FGF23). However, its role in the pathogenesis of ROP remains poorly understood. Objective. To evaluate the association between serum FGF23 levels in the early neonatal period and the severity of ROP in infants born at a gestational age of less than 32 weeks. Materials and Methods. This study involved 38 preterm infants: 18 with confirmed ROP (main group) and 20 without signs of ROP (control group). All participants underwent ophthalmological assessment according to the ICROP-3 (2021) and ETROP classification systems. Serum FGF23 levels were measured by chemiluminescent immunoassay (CLIA) from umbilical cord blood collected immediately after birth. Results. The mean serum FGF23 concentration was significantly higher in the ROP group compared to controls (p<0б001). A strong positive correlation was identified between FGF23 levels and ROP severity (r=0б71). Elevated FGF23 levels may contribute to the pathophysiology of ROP in preterm infants and could serve as a potential early biomarker for identifying those at risk of developing severe disease.

Retinopathy of prematurity, fibroblast growth factor 23 (FGF23), retinal angiogenesis

Bujoreanu Bezman L, Tiutiuca C, Totolici G, Carneciu N, Bujoreanu FC, Ciortea DA, Niculet E, Fulga A, Alexandru AM, Stan DJ, Nechita A. Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies. Int J Gen Med. 2023 Mar 14;16:937-949. doi: 10.2147/IJGM.S401122.

Rasoulinejad SA, Kiyamehr P. The Determinative Role of Cytokines in Retinopathy of Prematurity. Curr Mol Med. 2023;23(1):36-43. doi: 10.2174/1566524022666220117114920.

Almutairi M, Chechalk K, Deane E, Fox R, Janes A, Maguire-Henry T, McCabe D, O'Connor C, Quirk J, Swan E, White K, McCreery K, Isweisi E, Stewart P, Branagan A, Roche EF, Meehan J, Molloy EJ. Biomarkers in retinopathy of prematurity: a systematic review and meta-analysis. Front Pediatr. 2024 Mar 20;12:1371776. doi: 10.3389/fped.2024.1371776.

Wu PY, Fu YK, Lien RI, Chiang MC, Lee CC, Chen HC, Hsueh YJ, Chen KJ, Wang NK, Liu L, Chen YP, Hwang YS, Lai CC, Wu WC. Systemic Cytokines in Retinopathy of Prematurity. J Pers Med. 2023 Feb 5;13(2):291. doi: 10.3390/jpm13020291.

Fu Y, Lei C, Qibo R, Huang X, Chen Y, Wang M, Zhang M. Insulin-like growth factor-1 and retinopathy of prematurity: A systemic review and meta-analysis. Surv Ophthalmol. 2023 Nov-Dec;68(6):1153-1165. doi: 10.1016/j.survophthal.2023.06.010.

Kesting SJ, Nakwa FL. Prediction of Retinopathy of Prematurity Using the WINROP (Weight, IGF-1, Neonatal Retinopathy of Prematurity) Algorithm in a South African Population. Front Pediatr. 2022 Mar 23;10:812404. doi: 10.3389/fped.2022.812404.

Jafari N, Karimi Moghadam A, Taslimi Taleghani N, Hosseini Nezhad N, Motamed N, Jalilvand A. How is insulin-like growth factor-1 correlated with retinopathy of prematurity? J Res Med Sci. 2021 Nov 29;26:111. doi: 10.4103/jrms.JRMS_501_20.

Furuncuoglu U, Vural A, Kural A, Onur IU, Yigit FU. Serum vascular endothelial growth factor, insulin-like growth factor-1 and aflibercept levels in retinopathy of prematurity. Jpn J Ophthalmol. 2022 Mar;66(2):151-158. doi: 10.1007/s10384-021-00895-9.